Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
Fv-4 is a mouse gene that dominantly confers resistance to infection by ecotropic murine leukemia virus (MuLV). We demonstrated previously that the Fv-4 resistant (Fv-4r) gene product, Fv-4r env antigen, is released from Fv-4r-bearing BALB/c-Fv-4Wr (C4W) mouse-derived cells into serum in vivo and binds to cells expressing surface receptors for ecotropic MuLV, thereby protecting them from infection with Friend leukemia virus (FLV) by receptor interference. This unique resistance mechanism against retroviral infection might provide a possible therapeutic model system of human retroviral infection such as AIDS. To further investigate the Fv-4r gene action in vivo, we examined the distribution and character of Fv-4r env antigen in serum and systemic organs from C4W mice. The Fv-4r env antigen was immunohistochemically localized to the lympho-hematopoietic cells and exocrine glandular cells, such as those of the salivary gland and pancreas. Using immunoprecipitation followed by Western blotting, we determined two types of gp70-related Fv-4r env antigen in the serum of C4W mice, showing molecular weights of either 70-75 kDa and 80-85 kDa. When thymocytes from Fv-4 susceptible gene (Fv-4r)-bearing C3H mouse were mixed with C4W mouse serum, the 70-75k Da molecule of the C4W serum dominantly bound to C3H thymocytes and thus contributed to receptor interference function. Using immunoelectron microscopy, Fv-4r env antigen was mainly localized to the cell surface membrane of thymic lymphoid cells, while acinar cells of the salivary gland possessed Fv-4r env antigen in the endoplasmic reticulum (ER) as well as on the cell surface membrane. These data indicate that several glandular organs, as well as lymphohematopoietic organs of C4W mice, may contribute to the production of cell-free Fv-4r env antigen, resulting in protection of cells from infection with FLV by receptor interference.
Department of Pathology and Immunology, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
M
M
Kitagawa
S
S
Aizawa
H
H
Kamisaku
T
T
Sado
H
H
Ikeda
K
K
Hirokawa
D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D015153:Blotting, Western; D005260:Female; D005434:Flow Cytometry; D005622:Friend murine leukemia virus / Q000235:genetics; D015870:Gene Expression; D005799:Genes, Dominant; D007113:Immunity, Innate / Q000235:genetics; D007150:Immunohistochemistry; D007942:Leukemia, Experimental / Q000235:genetics / Q000276:immunology*; D008297:Male; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008854:Microscopy, Electron; D012333:RNA, Messenger / Q000378:metabolism; D011991:Receptors, Virus / Q000378:metabolism; D012192:Retroviridae Infections / Q000235:genetics / Q000276:immunology*; D014412:Tumor Virus Infections / Q000235:genetics / Q000276:immunology*
D000956:Antigens, Viral; C103555:Fv4 protein, mouse; D008565:Membrane Proteins; D012333:RNA, Messenger; D011991:Receptors, Virus